NCT04906798

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions

A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 High-dose in Healthy Volunteers Under Fasting Conditions

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 52 (estimated)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years – 54 Years
• Healthy volunteers: Accepted

Summary

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers under Fasting Conditions

Detailed description

A randomized, open-label, single dose, crossover study to evaluate the pharmacokinetic profiles and safety of CKD-385 high-dose in healthy volunteers under fasting conditions

Conditions

• Cardiovascular Diseases

Interventions

Type	Name	Description
DRUG	CKD-385	Test Drug
DRUG	D744	Reference Drug

Timeline

• Start date: 2021-06-04
• Primary completion: 2021-07-16
• Completion: 2021-07-23
• First posted: 2021-05-28
• Last updated: 2021-05-28

Locations

1 site across 1 country: South Korea